Shramko Svetlana Vladimirovna (RU),Шрамко Светлана Владимировна (RU),Vlasenko Anna Egorovna (RU),Власенко Анна Егоровна (RU),Bazhenova Lyudmila Grigorevna (RU),Баженова Людмила Григорьевна (RU),Likhac
申请号：
RU2018126913
公开号：
RU0002676035C1
申请日:
2018.07.20
申请国别(地区):
RU
年份:
2018
代理人:
摘要：
FIELD: medicine.SUBSTANCE: invention relates to the field of medicine, namely gynecology, and can be used to predict the likelihood of proliferating uterine fibroids. Immunological study is conducted. Anamnestic data is collected. Prognostic factors are determined. When collecting anamnestic data, the following is revealed: absence of childbirth, availability of abortions, surgery on the uterus, curettage of uterine cavity with concomitant adenomyosis, availability of thyroid disease in women in combination with endometrial hyperplasia, availability of atypical myoma nodes with circulatory disorders in them. Level of interleukin-6 (IL-6) and the level of alpha-2-glycoprotein (ABG) associated with pregnancy are determined in serum. Blood supply of myoma nodes is evaluated. Screening points (SP) for each factor are set. In the system “availability of abortions”, marker “available abortions” receives +8 points, marker “no abortions” receives 0 points. In the system “availability of surgery on the uterus”, marker “available operations on the uterus” receives +12 points, marker “no operations on the uterus” receives 0 points. In the system “availability of childbirth”, marker “available childbirth” receives 0 points, marker “no childbirth” receives +5 points. In the system “availability of curettage of uterine cavity with concomitant adenomyosis”, marker “available curettage of uterine cavity with concomitant adenomyosis” receives 0 points, marker, “available curettage of uterine cavity without concomitant adenomyosis” receives +10 points. In the system “availability of thyroid disease in women in combination with endometrial hyperplasia”, marker “availability of thyroid disease in women in combination with endometrial hyperplasia” receives 0 points, marker “availability of thyroid disease in women in combination without endometrial hyperplasia” receives +11 points. In the system “atypically located myoma nodes with an assessment of their blood supply”, marker “atypicall
